Chronic, non-communicable diseases present a significant global health burden, and a disproportionate one as well. The World Health organization (WHO) reports that cardiovascular diseases (CVDs) are the number one cause of death globally; more people die annually from CVDs than from any other cause . Low- and middle-income countries are disproportionally affected, representing more than 80 percent of all CVD deaths.
The disease focus of the research efforts at Baylor's Global Innovation Center are on chronic, non-communicable diseases, such as heart disease, diabetes, and cancer. . More than 60% of world’s total new annual cases of cancer occur in Africa, Asia and Central and South America; these regions account for 70% of the world’s cancer deaths. Both CVDs and many cancers share common behavioral and dietary risk factors and, like most diseases, they are most effectively and affordably treated when detected early. This focus complements the noteworthy international programs elsewhere at Baylor that have traditionally focused on infectious diseases (HIV), tropical diseases, and neglected diseases of poverty (malaria, malnutrition, parasites).
 Globocan 2012, Estimated Cancer Incidence, Mortality, and Prevalence Worldwide in 2012. WHO, IARC
Global Health Care Innovation Fund
The Global Health Care Innovation Fund, administered under the Baylor Global Innovation Center, provides Baylor faculty with funding for pilot studies in translational health research involving international partners and a focus on diseases that primarily affect medically underserved populations in low or middle income countries.
Studies will generate preliminary data to secure subsequent peer-reviewed state or federal funding, and projects with the potential for commercialization are given special consideration. Requests for proposals are issued every other year in May and submissions are reviewed by germane Baylor faculty to determine funding. Award amounts are up to $50,000 for a one-year funding period.